C12Y 201/01005
Betaine--homocysteine s-methyltransferase
Official title: Betaine--homocysteine S-methyltransferase (2.1.1.5)
C12Y201/01005 (Betaine--homocysteine s-methyltransferase) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 6
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 21 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for shortening lag phase duration in microorganisms15 Jan 2026US 2026/0015574 A1Yeda Research and Development Co. Ltd.
- Acetaminophen protein adducts and methods of use thereof7 Nov 2024US 2024/0368669 A1BioVentures, LLC
- Compositions and methods comprising plants with increased seed amino acid content12 Sep 2024US 2024/0301436 A1
- Acetaminophen adducts and methods of use thereof3 Oct 2019US 2019/0300931 A1BioVentures, LLC
- Acetaminophen adducts and methods of use thereof22 Jun 2017US 2017/0175166 A1Arkansas Children's Hospital Research Institute, Inc.
Most cited
By later US patents